Sig North Trading, Ulc Bausch Health Companies Inc. Transaction History
Sig North Trading, Ulc
- $4.84 Billion
- Q3 2025
A detailed history of Sig North Trading, Ulc transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Sig North Trading, Ulc holds 27,482 shares of BHC stock, worth $172,586. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,482
Previous 48,815
43.7%
Holding current value
$172,586
Previous $325,000
45.54%
% of portfolio
0.0%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding BHC
# of Institutions
262Shares Held
207MCall Options Held
2.54MPut Options Held
6.46M-
John Paulson Paulson & Co. Inc. | New York, Ny70.8MShares$444 Million16.32% of portfolio
-
Nomura Holdings Inc Tokyo, M015.7MShares$98.6 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$81.6 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$76.9 Million0.0% of portfolio
-
Royal Bank Of Canada Toronto, A610.5MShares$66 Million0.01% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.27B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...